These grants support new investigators who are beginning to establish their own laboratories that are no longer under the tutelage of a senior scientist mentor. Preference is given to proposals that focus on leukemia, lymphoma, myelodysplastic syndrome and multiple myeloma.
Funding & Duration
Grants are each worth up to USD $100,000 (approx. AUD $137,000) over one year.
Applicants must be within seven years of their first independent position. They are not required to be US citizens and projects undertaken outside the US will be considered. Applicants with a National Institutes of Health K08 or K23 award are also eligible. Applicants holding a R01 grant or equivalent, grants worth more than USD $175,000 (approx. AUD $240,000) per year or career development awards from other national foundations, are not supported.
Submission Requirements & Due Dates
- 1 February 2019 – Letter of Intent (LOI) submitted to Sponsor
- TBC – full applications submitted for internal review
- Please email email@example.com if you are considering applying for this scheme.
- See also: Submitting an Application to Research Services for Review